TempraMed Expands Digital Health With VIVI Cap Smart
VANCOUVER, BC, Dec. 26, 2025 — TempraMed Technologies Ltd., a medical technology innovator focused on temperature-sensitive medication protection, has...
cGxP compliance
ChemPartner Refreshes Brand to Signal Trusted Biopharma CRO Role
SHANGHAI and WATERTOWN, Mass., Jan. 1, 2026 — ChemPartner, a global contract research organization (CRO) serving the biopharmaceutical industry,...
FDA Clears Ascletis ASC30 Phase II Diabetes Study
HONG KONG, Jan. 5, 2026 — Ascletis Pharma Inc. announced that it has received Investigational New Drug (IND) clearance...
FDA Recall Highlights cGxP Failures at Gold Star Facility
MINNEAPOLIS, December 26, 2025 — Gold Star Distribution, Inc. has issued a sweeping recall of all FDA-regulated products stored...
Merck–U.S. Agreement Redefines Drug Access and Pricing
RAHWAY, New Jersey, United States — December 19, 2025 — Merck & Co., known globally as MSD, has reached...
Telix Reports Phase 3 Success and FDA Progress in Dx
MELBOURNE, Australia; INDIANAPOLIS, United States — December 22, 2025 — Telix Pharmaceuticals Limited has reported a major precision medicine...
Havih–India Partnership Expands BSL-4 Pharma R&D
HYDERABAD, India, Dec. 17, 2025 — Havih Envirosciences, a subsidiary of Maxwell Biosciences, announced a strategic partnership with the...
Clarius Achieves FDA AI Milestones and Profitable Growth
VANCOUVER, BC, Dec. 17, 2025 — Clarius Mobile Health, a global leader in AI-powered handheld ultrasound technology, reported a...
CDA Backs OPDIVO Plus YERVOY for First-Line CRC Care
MONTREAL, Dec. 17, 2025 — Bristol Myers Squibb Canada announced that Canada’s Drug Agency (CDA-AMC) has issued a positive...
NMPA Approves MYQORZO in China for Obstructive HCM
SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 — Cytokinetics, Incorporated (NASDAQ: CYTK) announced that MYQORZO® (aficamten) has received approval...